ST. LOUIS, June 7 /PRNewswire/ -- Everest Biomedical Instruments Company, based in St. Louis, announced today its alliance with New York University School of Medicine's Brain Research Laboratory (BRL). The agreement provides Everest with exclusive rights to a number of patents and patent applications from the laboratory. BRL's patented information covers the fields of electroencephalography (EEG), neurodiagnostics, neurotherapy, brain function scanning and anesthesia, analgesia and amnesia monitoring. Terms of the agreement were not disclosed. Access to BRL's intellectual property will accelerate Everest's commercialization of novel brain-state neurological assessment devices. Designed to assist physicians in screening and evaluating patients with an altered mental status, Everest's new product plans include creation of a handheld device, the BrainScope(TM), that produces automatic, functional brain-state assessments. The technology could lead to improved results and more efficient care for patients suffering from traumatic brain injuries, strokes, seizures, Alzheimer's disease and various psychiatric disorders. "Existing neurological diagnostic devices, such as computed tomography (CT) scanner, can identify structural or anatomical problems but cannot assess the brain's functional status in a timely manner," says Elvir Causevic, Everest Biomedical founder and president. "Moreover in emergency situations, definitive results from currently used tests can take hours or even days. By applying the BRL data to our proven handheld technology platform, we'll bring to market emergency-care tools that help physicians know within minutes the patient's functional brain status as an adjunct for relevant and timely treatment." "This university-industrial partnership with Everest allows us to take our 20 years of research and transform this knowledge into practical tools that will support physicians' practices, offer broad psychiatric clinical applications and benefit the general population," adds Roy John, Ph.D., NYU professor of psychiatry and Director of BRL. About Everest Biomedical Instruments Company Everest Biomedical Instruments Company products address unmet clinical needs in the areas of infant hearing screening, anesthesia monitoring and neurological assessment. The company's proprietary technology incorporates the sciences of electroencephalography, evoked potentials and computerized neurometric assessment. Using the latest advances in digital signal processing, patented applied mathematics and miniaturized hardware, Everest's handheld devices are capable of acquiring and automatically processing electrical brain patterns to provide functional neurological assessment at the patient's bedside. For more information, visit http://www.everest-co.com or call 866.662.8346.
SOURCE Everest Biomedical Instruments Company